172 related articles for article (PubMed ID: 35906501)
1. Evolution of healthcare costs for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller E; Matlaga BR; McVary K;
Int Urol Nephrol; 2022 Nov; 54(11):2797-2803. PubMed ID: 35906501
[TBL] [Abstract][Full Text] [Related]
2. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller EE; Matlaga BR; McVary K
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):269-273. PubMed ID: 34545201
[TBL] [Abstract][Full Text] [Related]
3. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
Speakman M; Kirby R; Doyle S; Ioannou C
BJU Int; 2015 Apr; 115(4):508-19. PubMed ID: 24656222
[TBL] [Abstract][Full Text] [Related]
4. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
[TBL] [Abstract][Full Text] [Related]
5. Trends in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia, 2004 to 2013: the Urologic Diseases in America Project.
Welliver C; Feinstein L; Ward JB; Fwu CW; Kirkali Z; Bavendam T; Matlaga BR; McVary KT;
J Urol; 2020 Jan; 203(1):171-178. PubMed ID: 31430232
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project.
Verhamme KM; Dieleman JP; Bleumink GS; van der Lei J; Sturkenboom MC; Artibani W; Begaud B; Berges R; Borkowski A; Chappel CR; Costello A; Dobronski P; Farmer RD; Jiménez Cruz F; Jonas U; MacRae K; Pientka L; Rutten FF; van Schayck CP; Speakman MJ; Sturkenboom MC; Tiellac P; Tubaro A; Vallencien G; Vela Navarrete R;
Eur Urol; 2002 Oct; 42(4):323-8. PubMed ID: 12361895
[TBL] [Abstract][Full Text] [Related]
7. Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A cohort study of Chinese elderly males.
Chen W; Man S; Wang B; Kadeerhan G; Huang X
Low Urin Tract Symptoms; 2022 May; 14(3):170-177. PubMed ID: 34882977
[TBL] [Abstract][Full Text] [Related]
8. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
[TBL] [Abstract][Full Text] [Related]
10. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.
Park JS; Koo KC; Kim HK; Chung BH; Lee KS
Medicine (Baltimore); 2019 Oct; 98(42):e17635. PubMed ID: 31626149
[TBL] [Abstract][Full Text] [Related]
11. Real-world data and treatment patterns of patients with lower urinary tract symptoms due to benign prostatic hyperplasia in Germany: an observational study using health insurance claims data.
Miernik A; Fritzsche J; Libutzki B; Malka V; Kilemnik I; Mohebbi D; May M; Gratzke C; Suarez-Ibarrola R
World J Urol; 2021 Dec; 39(12):4381-4388. PubMed ID: 34292368
[TBL] [Abstract][Full Text] [Related]
12. Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008.
Egan KB; Suh M; Rosen RC; Burnett AL; Ni X; Wong DG; McVary KT
Int J Clin Pract; 2015 Nov; 69(11):1316-25. PubMed ID: 26215544
[TBL] [Abstract][Full Text] [Related]
13. Depressive males have higher odds of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a retrospective cohort study based on propensity score matching.
Xiong Y; Zhang YC; Jin T; Qin F; Yuan JH
Asian J Androl; 2021; 23(6):633-639. PubMed ID: 33818525
[TBL] [Abstract][Full Text] [Related]
14. Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system.
De la Cuadra-Grande A; Rioja-Zuazu J; Domínguez-Esteban M; Torres E; Blissett R; Woodward E; Oyagüez I; Fernández-Arjona M
Expert Rev Pharmacoecon Outcomes Res; 2023 Jun; 23(5):499-510. PubMed ID: 36897833
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study.
Zhang W; Zhang X; Li H; Wu F; Wang H; Zhao M; Hu H; Xu K
BMJ Open; 2019 Jun; 9(6):e022792. PubMed ID: 31221864
[TBL] [Abstract][Full Text] [Related]
16. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L
BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
[TBL] [Abstract][Full Text] [Related]
17. Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.
De Nunzio C; Salonia A; Gacci M; Ficarra V
World J Urol; 2020 Nov; 38(11):2771-2779. PubMed ID: 32060633
[TBL] [Abstract][Full Text] [Related]
18. Lower urinary tract symptoms-Benign prostatic hyperplasia may increase the risk of subsequent inguinal hernia in a Taiwanese population: A nationwide population-Based cohort study.
Wu YH; Juan YS; Shen JT; Wang HS; Jhan JH; Lee YC; Geng JH
PLoS One; 2020; 15(6):e0234329. PubMed ID: 32511262
[TBL] [Abstract][Full Text] [Related]
19. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
[TBL] [Abstract][Full Text] [Related]
20. Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Viktrup L; Hayes RP; Wang P; Shen W
BMC Urol; 2012 Nov; 12():30. PubMed ID: 23134716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
